189 related articles for article (PubMed ID: 17557121)
1. Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1alpha-mediated tumor apoptotic switch.
Magnon C; Opolon P; Ricard M; Connault E; Ardouin P; Galaup A; Métivier D; Bidart JM; Germain S; Perricaudet M; Schlumberger M
J Clin Invest; 2007 Jul; 117(7):1844-55. PubMed ID: 17557121
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of antiangiogenic effects of human canstatin with a hypoxia-regulated transgene vector in lung cancer model.
Li YY; Qian GS; Huang GJ; Chen F; Qian P; Yu SC; Wang CZ; Li Q; Wang JC; Wu GM
Cancer J; 2006; 12(2):136-46. PubMed ID: 16630405
[TBL] [Abstract][Full Text] [Related]
3. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.
Wang WB; Zhou YL; Heng DF; Miao CH; Cao YL
Breast Cancer Res Treat; 2008 Jul; 110(2):283-95. PubMed ID: 17899369
[TBL] [Abstract][Full Text] [Related]
4. Antisense HIF-1alpha prevents acquired tumor resistance to angiostatin gene therapy.
Sun X; Vale M; Jiang X; Gupta R; Krissansen GW
Cancer Gene Ther; 2010 Aug; 17(8):532-40. PubMed ID: 20348876
[TBL] [Abstract][Full Text] [Related]
5. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia.
Kaidi A; Qualtrough D; Williams AC; Paraskeva C
Cancer Res; 2006 Jul; 66(13):6683-91. PubMed ID: 16818642
[TBL] [Abstract][Full Text] [Related]
6. Significance of HIF-1-active cells in angiogenesis and radioresistance.
Harada H; Kizaka-Kondoh S; Li G; Itasaka S; Shibuya K; Inoue M; Hiraoka M
Oncogene; 2007 Nov; 26(54):7508-16. PubMed ID: 17563752
[TBL] [Abstract][Full Text] [Related]
7. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma.
Das B; Yeger H; Tsuchida R; Torkin R; Gee MF; Thorner PS; Shibuya M; Malkin D; Baruchel S
Cancer Res; 2005 Aug; 65(16):7267-75. PubMed ID: 16103078
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition.
Dang DT; Chun SY; Burkitt K; Abe M; Chen S; Havre P; Mabjeesh NJ; Heath EI; Vogelzang NJ; Cruz-Correa M; Blayney DW; Ensminger WD; St Croix B; Dang NH; Dang LH
Cancer Res; 2008 Mar; 68(6):1872-80. PubMed ID: 18339868
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha.
Zhang X; Kon T; Wang H; Li F; Huang Q; Rabbani ZN; Kirkpatrick JP; Vujaskovic Z; Dewhirst MW; Li CY
Cancer Res; 2004 Nov; 64(22):8139-42. PubMed ID: 15548675
[TBL] [Abstract][Full Text] [Related]
10. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
Menendez JA; Vellon L; Oza BP; Lupu R
J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor-activated NF-kappaB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines.
Tacchini L; De Ponti C; Matteucci E; Follis R; Desiderio MA
Carcinogenesis; 2004 Nov; 25(11):2089-100. PubMed ID: 15240510
[TBL] [Abstract][Full Text] [Related]
12. Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins.
Magnon C; Galaup A; Mullan B; Rouffiac V; Bouquet C; Bidart JM; Griscelli F; Opolon P; Perricaudet M
Cancer Res; 2005 May; 65(10):4353-61. PubMed ID: 15899827
[TBL] [Abstract][Full Text] [Related]
13. Noscapine inhibits hypoxia-mediated HIF-1alpha expression andangiogenesis in vitro: a novel function for an old drug.
Newcomb EW; Lukyanov Y; Schnee T; Ali MA; Lan L; Zagzag D
Int J Oncol; 2006 May; 28(5):1121-30. PubMed ID: 16596228
[TBL] [Abstract][Full Text] [Related]
14. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
15. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.
Carmeliet P; Dor Y; Herbert JM; Fukumura D; Brusselmans K; Dewerchin M; Neeman M; Bono F; Abramovitch R; Maxwell P; Koch CJ; Ratcliffe P; Moons L; Jain RK; Collen D; Keshert E
Nature; 1998 Jul; 394(6692):485-90. PubMed ID: 9697772
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I.
Catrina SB; Botusan IR; Rantanen A; Catrina AI; Pyakurel P; Savu O; Axelson M; Biberfeld P; Poellinger L; Brismar K
Clin Cancer Res; 2006 Aug; 12(15):4506-14. PubMed ID: 16899596
[TBL] [Abstract][Full Text] [Related]
17. Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappaB activity in hypoxic tumor cells.
Jang GY; Jeon JH; Cho SY; Shin DM; Kim CW; Jeong EM; Bae HC; Kim TW; Lee SH; Choi Y; Lee DS; Park SC; Kim IG
Oncogene; 2010 Jan; 29(3):356-67. PubMed ID: 19838207
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS; Simons JW
Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
[TBL] [Abstract][Full Text] [Related]
19. The role and regulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury.
Fan X; Heijnen CJ; van der Kooij MA; Groenendaal F; van Bel F
Brain Res Rev; 2009 Dec; 62(1):99-108. PubMed ID: 19786048
[TBL] [Abstract][Full Text] [Related]
20. Hammerhead ribozyme targeting human hypoxia inducible factor-1alpha gene effectively attenuates HeLa xenograft tumors.
Yu R; Chen R; Shi Q; Li T; Tang H
Surg Neurol; 2009 Aug; 72 Suppl 1():S8-S16; discussion S16. PubMed ID: 18514274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]